This has been my concern from the start. What we say we are doing sounds great, but what are we actually doing. We really havent heared all that much in progress i dont think since we started down the myc trail. I know we are doing data packs etc but the bottom line is do we have a proprietry myc inhibitor that is useable, and are we actually able to target specific cell types with cpp's. Neither question has been answered.
I would certainly like to know exactly where we are at now after another year has gone by, but generally that doesnt seem to be a popular request on this site. I cant even get a reply from Richard.
PYC has competition, page-6
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
-0.015(8.11%) |
Mkt cap ! $793.2M | |||
| Open | High | Low | Value | Volume |
| 18.0¢ | 18.0¢ | 17.0¢ | $419.2K | 2.405M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 326555 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 222720 | 4 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| PYC (ASX) Chart |